Fenofibrate for Compensated Cirrhosis Patients With Primary Biliary Cholangitis
Condition:   Primary Biliary Cholangitis Interventions:   Drug: Fenofibrate 200mg;   Drug: Placebo;   Drug: UDCA Sponsor:   Xijing Hospital of Digestive Diseases Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 1, 2023 Category: Research Source Type: clinical trials

Genetic-Dependent Cardiovascular Response to PPAR-Alpha Agonist Fenofibrate
Conditions:   Type 2 Diabetes;   Cardiovascular Diseases;   Pharmacogenomic Drug Interaction Interventions:   Drug: Fenofibrate 145 mg;   Drug: Placebo Sponsor:   Mario Luca Morieri Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 15, 2022 Category: Research Source Type: clinical trials